 |
|
Cortical Blindness After Metrizamide MyelographyReport of a Case and Proposed Pathophysiologic Mechanism
James G. Smirniotopoulos, MD;
Frances M. Murphy, MD;
Dieter Schellinger, MD;
John F. Kurtzke, MD;
Frederick T. Borts, MD
Arch Neurol. 1984;41(2):224-226.
Abstract
• Metrizamide, a nonionic, water-soluble contrast medium, has been increasingly used for myelography. We saw a patient with cortical blindness, seizure, organic psychosis, and asterixis after undergoing attempted metrizamide myelography via C1-2 puncture. Computed tomography demonstrated early penetrance of metrizamide into the brain parenchyma, most prominently in the occipital lobes. A mechanism of direct metrizamide neurotoxicity was proposed.
Author Affiliations
From the Departments of Radiology (Drs Smirniotopoulos, Schellinger, and Borts) and Neurology (Drs Murphy and Kurtzke), Georgetown University Hospital, and the Department of Neurology, Veterans Administration Hospital (Dr Kurtzke), Washington, DC.
Footnotes
Accepted for publication March 3, 1983.
Reprint requests to Neuroradiology Section, Division of Radiologic Pathology, Armed Forces Institute of Pathology, Washington, DC 20306 (Dr Smirniotopoulos).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Cortical Blindness after Contrast-Enhanced CT: Complication in a Patient with Diabetes Insipidus
Mentzel et al.
Am. J. Neuroradiol. 2003;24:1114-1116.
ABSTRACT
| FULL TEXT
An Unusual Case of Cortical Blindness Associated with Aortography: A Case Report
Sabovic et al.
ANGIOLOGY 2000;51:151-154.
ABSTRACT
Cortical Blindness Following Coronary Arteriography: A Rare But Self-Cured Complication: Two Case Reports
Antonellis et al.
ANGIOLOGY 1996;47:803-806.
ABSTRACT
Transient Cortical Blindness Following Bypass Graft Angiography: A Case Report
Kamata et al.
ANGIOLOGY 1995;46:937-946.
ABSTRACT
Neurotoxicity of Metrizamide
Ekholm and Fischer
Arch Neurol 1985;42:24-25.
ABSTRACT
|
